Contract V797D70098
Aprecia Pharmaceuticals Company · Department Of Veterans Affairs · February 22, 2017
Aprecia Pharmaceuticals Company was awarded a federal contract by Department Of Veterans Affairs on February 22, 2017 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 12 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on February 13, 2026. If all options are exercised, the contract could reach $9.00 million.
Contract details
- PIID
- V797D70098
- Award type
- —
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- February 22, 2017
- Latest action
- February 13, 2026
Description
SHORT TERM EXT
Modification timeline
-
February 13, 2026Mod P00018$0
-
December 4, 2025Mod P000172026 PUBLIC LAW$0
-
September 30, 2025Mod P00016ADMIN$0
-
February 11, 2025Mod P00015CONTRACT EXTENSION$0
-
December 3, 2024Mod P000142025 PUBLIC LAW$0
-
June 12, 2024Mod P00013ADMIN - POC$0
-
February 14, 2024Mod P00012CONTRACT EXTENSION$0
-
November 28, 2022Mod P00009PL 2023$0
-
February 14, 2022Mod P00008SHORT TERM EXTENSION$0
-
December 1, 2021Mod P00007PL 2022$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract V797D70098?
Contract V797D70098 is a federal contract awarded to Aprecia Pharmaceuticals Company by Department Of Veterans Affairs on February 22, 2017 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 12 times since the base award.
Who won contract V797D70098?
Aprecia Pharmaceuticals Company won contract V797D70098 from Department Of Veterans Affairs.
How much is contract V797D70098 worth?
Contract V797D70098 has obligated $0 to date but carries a potential ceiling of $9.00 million if fully funded and all options are exercised.